Patients with a rare and aggressive form of liposarcoma need treatment advances
Patients with a rare and aggressive form of liposarcoma need treatment advances
Search
Full data announced in DINAMO trial in young people with T2D
Jardiance (empagliflozin) tablets is the first SGLT2 inhibitor to show statistically significant
Heart Failure
Heart Failure
Recognizing Parents Supporting Other Parents
Recognizing Parents Supporting Other Parents
directions_from_bay_area_airports_to_boehringer.pdf
Our Transformative Team Culture
Our transformative team culture
Patient Centricity
Patient Centricity
Office Hours Program | Partnering
Click here to find out how Boehringer Ingelheim's pioneering ‘Office Hours’ program has now mentored over 250 early-stage companies since 2015.
Contact Us
Contact Us
Kei Kato
Kei Kato, Head of Purchasing in Japan, describes a career at Boehringer Ingelheim as intense and exciting.
Boehringer Ingelheim bpcia Strength citizen petition
Code-of-Conduct-Boehringer-Ingelheim_0.pdf
Boehringer Ingelheim Invests in You
Post-Traumatic Stress Disorder | PDF | Boehringer Ingelheim US
Patient-centric cardio-renal-metabolic disease research at Boehringer Ingelheim
BIPI Post Marketing Requirements PDF | Boehringer Ingelheim US
Imprint | Boehringer Ingelheim US
Imprint
Carolina Valoyes | Boehringer Ingelheim Careers
Carolina Valoyes talks about her career in the Quality division and what is next for her in the company.
Press Releases | Boehringer Ingelheim US
Press Releases
Animal Health | COVID-19 | Boehringer Ingelheim US
Click here to read more on how the COVID-19 pandemic has impacted the daily lives of veterinarians, livestock producers and others.
Contact Our Team | Human Health | Boehringer Ingelheim US
Find all our contact information here as well as the latest updates on where you can meet our partnering teams virtually or in person.
Fostering Science | Boehringer Ingelheim US
Find out how creating breakthrough medicines to change patients’ lives starts with a commitment to identify the challenges of the future & emerging science.
Partnering-Boehringer-Ingelheim.pdf
Sustainable Development for Generations | Boehringer Ingelheim US
At BI, Sustainable Development – For Generations is about a journey. One that started in 1885 and one that we hope, and believe, will never end.
Clinical Development and Operations
Click here to find out more on how Boehringer Ingelheim is proud to offer a new 2-year Fellowship program within Clinical Operations.